Anticipation in familial pancreatic cancer

Gut

Volumn 55, Issue 2, 2006, Pages 252-258

  McFaul, C D ^b   Greenhalf, W ^a,b   Earl, J ^b   Howes, N ^b   Neoptolemos, J P ^b   Kress, R ^c   Sina Frey, M ^c   Rieder, H ^c   Hahn, S ^d   Bartsch, D K ^c  

^a UCD Building ^*  (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANTICIPATION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CHILD; CHILD DEATH; EUROPE; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; ANTICIPATION, GENETIC; EPIDEMIOLOGIC METHODS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PANCREATIC NEOPLASMS; PEDIGREE; SMOKING;

EID: 30944451530     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.065045     Document Type: Article

References (51)

1. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
2. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003;103:525-30.
3. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-8.
4. Bartsch DK, Kress R, Sina-Frey M, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer 2004;110:902-6.
5. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993;34:1394-6.
6. The Breast Cancer Linkage Consortium: Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999;91:1310-16.
7. Giardiello FM, Brensinger JD, Tersmelte AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-53.
8. Bartsch DK, Sina-Frey M, Lang S, et al. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 2002;236:730-7.
9. Lynch HT, Brand RE, Hogg D, et al. Phenolypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002;94:84-96.
10. Klein AP, Beaty TH, Bailey-Wilson JE, et al. Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 2002;23:133-49.
11. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003;95:214-21.
12. Eberle MA, Pfutzer R, Pogue-Geile KL, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 2002;70:1044-8.
13. Sutherland GR, Richards RI. Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A 1995;92:3636-41.
14. Kehoe P, Krawczak M, Harper PS, et al. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 1999;36:108-11.
15. Grandbastien B, Peeters M, Franchimont D, et al. Anticipation in familial Crohn's disease. Gut 1998;42:170-4.
16. Annese V, Andreoli A, Astegiano M, et al. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum. Am J Gastroenterol 2001;96:2939-45.
17. Radstake TR, Barrera P, Albers MJ, et al. Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families. J Rheumatol 2001;28:962-7.
18. Paterson AD, Kennedy JL, Petronis A. Evidence for genetic anticipation in non-Mendelian diseases. Am J Hum Genet 1996;59:264-8.
19. Siegel AM, Andermann F, Badhwar A, et al. Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand 1998;98:372-6.
20. De Lord C, Powles R, Mehta J, et al. Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. Br J Haematol 1998;100:557-60.
21. Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia. Am J Hum Genet 1996;59:990-8.
22. Yuille MR, Houlston RS, Catovsky D. Anticipation in familial chronic lymphocytic leukaemia. Leukemia 1998;12:1696-8.
23. Wiernik PH, Wang SQ, Hu XP, et al. Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma. Br J Haematol 2000;108:72-9.
24. Shugart YY, Hemminki K, Vaittinen P, et al. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet 2000;106:553-6.
25. Shugart YY, Hemminki K, Vaittinen P, et al. Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin's and non-Hodgkin's lymphoma: report from a study based on Swedish cancer database. Leuk lymphoma 2001;42:407-15.
26. Goldstein AM, Clark WH Jr, Fraser MC, et al. Apparent anticipation in familial melanoma. Melanoma Res 1996;6:441-6.
27. Wong T, Howes N, Threadgold J, et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high risk patients. Pancreatology 2001;1:486-509.
28. Rulyak SJ, Kimmey MB, Veenstra DL, et al. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003;57:23-9.
29. Rieder H, Sina-Frey M, Ziegler A, et al. German national case collection of familial pancreatic cancer-clinical-genetic analysis of the first 21 families. Onkologie 2002;25:262-6.
30. Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-9.
31. Tsai YY, Petersen GM, Booker SV, et al. Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiol 1997;14:435-46.
32. Faybush EM, Blanchard JF, Rawsthorne P, et al. Generational differences in the age at diagnosis with lbd: genetic anticipation, bias, or temporal effects. Am J Gastroenterol 2002;97:636-40.
33. Fraser FC. Trinucleotide repeats not the only cause of anticipation. Lancet 1997;350:459-60.
34. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-61.
35. Hsu L, Zhao LP, Malone KE, et al. Assessing changes in ages at onset over successive generation: an application to breast cancer. Genet Epidemiol 2000;18:17-32.
36. Picco MF, Goodman S, Reed J, et al. Methodologic pitfalls in the determination of genetic anticipation: the case or Crohn disease. Ann Intern Mead 2001;134:1124-9.
37. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111-15.
38. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
39. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
40. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232:786-95.
41. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):4-66.
42. Hruban RH, Canto MI, Yeo O. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer. Dig Dis 2001;19:76-84.
43. Coughlin SS, Calle EE, Patel AV, et al. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000;11:915-23.
44. Boyle P, Maisonneuve P, Bueno de Mesquita B, et al. Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer 1996;67:63-71.
45. Kemm JR. A birth cohort analysis of smoking by adults in Great Britain 1974-1998. J Public Health Med 2001;23:306-11.
46. Trkova M, Hladikova M, Kasal P, et al. Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome? J Hum Genet 2002;47:381-6.
47. Paterson AD, Naimark DM, Huang J, et al. Genetic anticipation and breast cancer: a prospective follow-up study. Breast Cancer Res Treat 1999;55:21-8.
48. McInnis MG. Anticipation: an old idea in new genes. Am J Hum Genet 1996;59:973-9.
49. Petronis A, Kennedy JL, Paterson AD. Genetic anticipation: fact or artifact, genetics or epigenetics? Lancet 1997;350:1403-4.
50. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 1997;60:1079-84.
51. Dagan E, Gershoni-Baruch R. Anticipation in hereditary breast cancer. Clin Genet 2002;62:147-50.